Table 2.
Correlation analysis |
Regression analysis |
|||
---|---|---|---|---|
r | p | 95% CI | p | |
Age | 0.42 | <0.001 | 0.03 – 0.09 | <0.001 |
Male gender | 0.21 | 0.04 | 0.48 – 1.55 | 0.03 |
Hypertension | 0.06 | 0.41 | – | – |
Diabetes | 0.06 | 0.44 | – | – |
Smoking | 0.05 | 0.79 | – | – |
Dyslipidemia | 0.16 | 0.06 | −1.4 – 0.21 | 0.16 |
BMI | 0.20 | <0.001 | −0.02 – 0.08 | 0.22 |
ELC | 0.31 | <0.001 | 0.61 – 1.74 | 0.009 |
Cardiovascular medication | ||||
ACE inhibitors or ARB | −0.02 | 0.76 | – | – |
Calcium channel blockers | 0.15 | 0.40 | – | – |
β-Blockers | −0.21 | 0.07 | −0.56 – 1.34 | 0.41 |
Cholesterol-lowering drugs | −0.17 | 0.03 | −2.52 – 0.78 | 0.29 |
Aspirin | 0.05 | 0.26 | – | – |
ACE = Angiotensin-converting enzyme; ARB = angiotensin receptor blocker.